1. A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects. (August 2021) Authors: Cheung, Dorothy; Fong, Alice; Ding, Han Ting; Cabanski, Christopher R.; Wang, Jianshuang; Chen, Yuan; Bush, Jim; Harris, Jeffrey M.; Pan, Lin Journal: Pulmonary pharmacology & therapeutics Issue: Volume 69(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects. (19th January 2017) Authors: Harada, Tomohiko; Wilbraham, Darren; de La Borderie, Guillemette; Inoue, Shinsuke; Bush, Jim; Camm, A. John Journal: British journal of clinical pharmacology Issue: Volume 83:Number 5(2017:May) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of interleukin‐10 on cutaneous wounds and scars in humans of African continental ancestral origin. Issue 3 (May 2014) Authors: Kieran, Ingrid; Taylor, Catherine; Bush, Jim; Rance, Mark; So, Karen; Boanas, Adam; Metcalfe, Anthony; Hobson, Rosalind; Goldspink, Nick; Hutchison, John; Ferguson, Mark Journal: Wound repair and regeneration Issue: Volume 22:Issue 3(2014) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mitigation of Initial Cardiodynamic Effects of the S1P1 Receptor Modulator Ponesimod Using a Novel Up‐Titration Regimen. (30th September 2016) Authors: Juif, Pierre‐Eric; Hoch, Matthias; Vaclavkova, Andrea; Krause, Andreas; Bush, Jim; Dingemanse, Jasper Journal: Journal of clinical pharmacology Issue: Volume 57:Number 3(2017) Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and efficacy of an extended‐release peptide YY analogue for obesity: A randomized, placebo‐controlled, phase 1 trial. Issue 7 (9th March 2021) Authors: Tan, Tricia M.‐M.; Minnion, James; Khoo, Bernard; Ball, Laura‐Jayne; Malviya, Reshma; Day, Emily; Fiorentino, Francesca; Brindley, Charlie; Bush, Jim; Bloom, Stephen R. Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 7(2021) Page Start: 1471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Therapies with Emerging Evidence of Efficacy: Avotermin for the Improvement of Scarring. (20th July 2010) Authors: Bush, Jim; So, Karen; Mason, Tracey; Occleston, Nick L.; O'Kane, Sharon; Ferguson, Mark W. J. Other Names: Gladstone Hayes B. Academic Editor. Journal: Dermatology research and practice Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Therapies with Emerging Evidence of Efficacy: Avotermin for the Improvement of Scarring. (20th July 2010) Authors: Bush, Jim; So, Karen; Mason, Tracey; Occleston, Nick L.; O'Kane, Sharon; Ferguson, Mark W. J. Other Names: Gladstone Hayes B. Academic Editor. Journal: Dermatology research and practice Issue: Volume 2010(2010) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0186 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF MBS2320, A SELECTIVE MODULATOR OF IMMUNE METABOLISM, IN HEALTHY VOLUNTEERS AND PATIENTS WITH RHEUMATOID ARTHRITIS. (June 2019) Authors: Patel, Lisa; Marcus, Paul; Bush, Jim; Gray, Andy; Fitzgerald, Richard; Abraham, Sonya; Foster, Martyn; Huatan, Hiep; Skillern, Laurence; Daroszewska, Anna; Hof, Rob Van't; Williams, Sam Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗